Amyloidosis Africa
Amyloidosis Africa advocates for the recognition of amyloidosis as a priority condition within African health systems. We engage decision-makers to ensure amyloidosis is included in cardiovascular, rare disease, and non-communicable disease strategies.
Without advocacy, amyloidosis remains excluded from policy discussions, funding decisions, and diagnostic planning. Advocacy is essential to unlock access to diagnostics, treatment pathways, and long-term care.
We work with professional societies, ministries of health, and regional stakeholders to elevate amyloidosis on national and continental agendas. Our advocacy is evidence-based, patient-centered, and aligned with health equity goals.
Leave a Reply